1D 1 H NMR as a Tool for Fecal Metabolomics |
|
81 Transplantation of Dysbiotic Microbiota Derived From UC Patients Promotes a Pro-Inflammatory Phenotype and Increased Susceptibility of Gnotobiotic Mice to Colitis |
|
Administration of defined microbiota is protective in a murine Salmonella infection model. |
|
Amino acid residues within enterohemorrhagic Escherichia coli O157:H7 Tir involved in phosphorylation, alpha-actinin recruitment, and Nck-independent pedestal formation |
|
Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. |
|
Antivirulence activity of the human gut metabolome. |
|
Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative |
|
Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children |
|
Bioactive small molecules produced by the human gut microbiome modulate <i>Vibrio cholerae</i> sessile and planktonic lifestyles |
|
Bringing the gut microbiota into focus through microbial culture: recent progress and future perspective |
|
A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics |
|
A carboxy-terminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion. |
|
A catalog of reference genomes from the human microbiome |
|
Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
|
Chemostat culture systems support diverse bacteriophage communities from human feces. |
|
Circadian influence on the microbiome improves heart failure outcomes |
|
Co-occurrence of anaerobic bacteria in colorectal carcinomas. |
|
A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity |
|
Colonizing the embryonic zebrafish gut with anaerobic bacteria derived from the human gastrointestinal tract |
|
Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene |
|
Complete genome sequences and analysis of the Fusobacterium nucleatum subspecies animalis 7-1 bacteriophage ɸFunu1 and ɸFunu2 |
|
Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome |
|
Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing. |
|
Delivery mechanism can enhance probiotic activity against honey bee pathogens |
|
Drivers of human gut microbial community assembly: coadaptation, determinism and stochasticity |
|
Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model |
|
Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro |
|
Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile |
|
Enteropathogenic Escherichia coli Tir translocation and pedestal formation requires membrane cholesterol in the absence of bundle-forming pili. |
|
Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. |
|
Evolution of invasion in a diverse set of Fusobacterium species |
|
FplA From Fusobacterium nucleatum Is A Type Vd Autotransporter Phospholipase With A Proposed Role In Altered Host Signaling And Evasion Of Autophagy |
|
Function is what counts: how microbial community complexity affects species, proteome and pathway coverage in metaproteomics |
|
Fusobacterium and Enterobacteriaceae: important players for CRC? |
|
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma |
|
Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha |
|
Fusobacterium varium in ulcerative colitis: is it population-based? |
|
A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria |
|
Guelph Family Health Study: pilot study of a home-based obesity prevention intervention |
|
Gut microbial biofilm composition and organisation holds the key to CRC |
|
Holtiella tumoricola gen. nov. sp. nov., isolated from a human clinical sample |
|
A human gut ecosystem protects against C. difficile disease by targeting TcdA. |
|
The Human Gut Microbial Metabolome Modulates Fungal Growth via the TOR Signaling Pathway |
|
The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts |
|
The human microbiome handbook, 2016: |
|
Impact of food grade and nano-TiO2 particles on a human intestinal community |
|
Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice |
|
Invasion by Fusobacterium nucleatum Causes Upregulation of dll4 and klf4 Expression in Caco2 Cells |
|
Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. |
|
Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat. |
|
Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health |
|
Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities |
|
Metagenomics-Based, Strain-Level Analysis of Escherichia coli From a Time-Series of Microbiome Samples From a Crohn's Disease Patient |
|
Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. |
|
Microbial Interactions and Interventions in Colorectal Cancer |
|
The microbiome: what it means for medicine |
|
A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice |
|
Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications |
|
Optimization of metabolomics of defined in vitro gut microbial ecosystems. |
|
Perspectives for Consideration in the Development of Microbial Cell Reference Materials |
|
Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. |
|
Phylogenetic Clustering of Genes Reveals Shared Evolutionary Trajectories and Putative Gene Functions |
|
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood |
|
Protease-dependent excitation of nodose ganglion neurons by commensal gut bacteria |
|
Quantitative proteomic profiling of shake-flask versus bioreactor growth reveals distinct responses of <i>Agrobacterium tumefaciens</i> for preparation in molecular pharming |
|
Rarimicrobium hominis gen. nov., sp. nov., representing the fifth genus in the phylum Synergistetes that includes human clinical isolates |
|
Rebooting the microbiome |
|
A review of the associations between single nucleotide polymorphisms in taste receptors, eating behaviors, and health. |
|
Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge |
|
Simulating distal gut mucosal and luminal communities using packed-column biofilm reactors and an in vitro chemostat model |
|
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. |
|
Strain specificity in fusobacterial co-aggregation with colorectal cancer-relevant species |
|
Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing |
|
Towards standards for human fecal sample processing in metagenomic studies. |
|
Tracing incorporation of heavy water into proteins for species-specific metabolic activity in complex communities |
|
Using bioreactors to study the effects of drugs on the human microbiota |
|
A vaccine and diagnostic target for Clostridium bolteae, an autism-associated bacterium. |
|